Literature DB >> 25485359

Tumor growth prediction with hyperelastic biomechanical model, physiological data fusion, and nonlinear optimization.

Ken C L Wong, Ronald M Summers, Electron Kebebew, Jianhua Yao.   

Abstract

Tumor growth prediction is usually achieved by physiological modeling and model personalization from clinical measurements. Although image-based frameworks have been proposed with promising results, different issues such as infinitesimal strain assumption, complicated optimization procedures, and lack of functional information, may limit the prediction performance. Therefore, we propose a framework which comprises a hyperelastic biomechanical model for better physiological plausibility, gradient-free nonlinear optimization for more flexible choices of models and objective functions, and physiological data fusion of structural and functional images for better subject-specificity. Experiments were performed on synthetic and clinical data to verify parameter estimation capability and prediction performance of the framework. Comparisons of using different biomechanical models and objective functions were also performed. From the experimental results on eight patient data sets, the recall, precision, and relative volume difference (RVD) between predicted and measured tumor volumes are 84.85 ± 6.15%, 87.08 ± 7.83%, and 13.81 ± 6.64% respectively.

Entities:  

Mesh:

Year:  2014        PMID: 25485359      PMCID: PMC4306389          DOI: 10.1007/978-3-319-10470-6_4

Source DB:  PubMed          Journal:  Med Image Comput Comput Assist Interv


  7 in total

1.  A general model for ontogenetic growth.

Authors:  G B West; J H Brown; B J Enquist
Journal:  Nature       Date:  2001-10-11       Impact factor: 49.962

Review 2.  Intravenous contrast medium administration and scan timing at CT: considerations and approaches.

Authors:  Kyongtae T Bae
Journal:  Radiology       Date:  2010-07       Impact factor: 11.105

3.  Realistic simulation of the 3-D growth of brain tumors in MR images coupling diffusion with biomechanical deformation.

Authors:  Olivier Clatz; Maxime Sermesant; Pierre-Yves Bondiau; Hervé Delingette; Simon K Warfield; Grégoire Malandain; Nicholas Ayache
Journal:  IEEE Trans Med Imaging       Date:  2005-10       Impact factor: 10.048

4.  Extravascular contrast material: the major component of contrast enhancement.

Authors:  M Kormano; P B Dean
Journal:  Radiology       Date:  1976-11       Impact factor: 11.105

5.  Causes, consequences, and remedies for growth-induced solid stress in murine and human tumors.

Authors:  Triantafyllos Stylianopoulos; John D Martin; Vikash P Chauhan; Saloni R Jain; Benjamin Diop-Frimpong; Nabeel Bardeesy; Barbara L Smith; Cristina R Ferrone; Francis J Hornicek; Yves Boucher; Lance L Munn; Rakesh K Jain
Journal:  Proc Natl Acad Sci U S A       Date:  2012-08-29       Impact factor: 11.205

6.  Kidney tumor growth prediction by coupling reaction-diffusion and biomechanical model.

Authors:  Xinjian Chen; Ronald M Summers; Jianhua Yao
Journal:  IEEE Trans Biomed Eng       Date:  2012-10-02       Impact factor: 4.538

7.  An image-driven parameter estimation problem for a reaction-diffusion glioma growth model with mass effects.

Authors:  Cosmina Hogea; Christos Davatzikos; George Biros
Journal:  J Math Biol       Date:  2007-11-17       Impact factor: 2.259

  7 in total
  3 in total

1.  Predicting in vivo glioma growth with the reaction diffusion equation constrained by quantitative magnetic resonance imaging data.

Authors:  David A Hormuth; Jared A Weis; Stephanie L Barnes; Michael I Miga; Erin C Rericha; Vito Quaranta; Thomas E Yankeelov
Journal:  Phys Biol       Date:  2015-06-04       Impact factor: 2.583

Review 2.  How Sensor, Signal, and Imaging Informatics May Impact Patient Centered Care and Care Coordination.

Authors:  S Voros; A Moreau-Gaudry
Journal:  Yearb Med Inform       Date:  2015-08-13

3.  Reconstruction of a Deformed Tumor Based on Fiducial Marker Registration: A Computational Feasibility Study.

Authors:  Ye Han; Emily Oakley; Gal Shafirstein; Yoed Rabin; Levent Burak Kara
Journal:  Technol Cancer Res Treat       Date:  2018-01-01
  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.